Literature DB >> 20425635

Extracorporeal stereotactic radiosurgery for small renal masses.

Gino J Vricella1, Nicholas A Boncher, Lee E Ponsky.   

Abstract

Over the past decade we have witnessed both a grade and stage migration for renal cell carcinoma. This shift in clinicopathology has been met with a paradigm shift in the treatment of these renal mass lesions. This trend has evolved from laparoscopic extirpation to needle-based and now extracorporeal ablation. At the forefront of the extracorporeal, minimally invasive treatment modalities is radiosurgical ablation. Still in its inaugural phase, renal radiosurgery is devoid of any long-term studies; however, short-term studies thus far show enormous potential. Herein we present the current status of radiosurgical ablation of small renal masses.

Entities:  

Mesh:

Year:  2010        PMID: 20425635     DOI: 10.1007/s11934-009-0088-6

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  18 in total

1.  Initial evaluation of Cyberknife technology for extracorporeal renal tissue ablation.

Authors:  Lee E Ponsky; Richard L Crownover; Michael J Rosen; Raymond F Rodebaugh; Elias A Castilla; Jennifer Brainard; Edward E Cherullo; Andrew C Novick
Journal:  Urology       Date:  2003-03       Impact factor: 2.649

2.  The natural history of incidentally detected small renal masses.

Authors:  Andrew Renshaw
Journal:  Cancer       Date:  2004-08-01       Impact factor: 6.860

Review 3.  Conservative vs radical surgery for renal cell carcinoma.

Authors:  Hein Van Poppel
Journal:  BJU Int       Date:  2004-10       Impact factor: 5.588

Review 4.  Increased incidence of serendipitously discovered renal cell carcinoma.

Authors:  M Jayson; H Sanders
Journal:  Urology       Date:  1998-02       Impact factor: 2.649

Review 5.  The natural history of observed enhancing renal masses: meta-analysis and review of the world literature.

Authors:  Sam N Chawla; Paul L Crispen; Alexandra L Hanlon; Richard E Greenberg; David Y T Chen; Robert G Uzzo
Journal:  J Urol       Date:  2006-02       Impact factor: 7.450

6.  Phase II trial of radiosurgery for one to three newly diagnosed brain metastases from renal cell carcinoma, melanoma, and sarcoma: an Eastern Cooperative Oncology Group study (E 6397).

Authors:  Rafael Manon; Anne O'Neill; Jonathan Knisely; Maria Werner-Wasik; Hillard M Lazarus; Henry Wagner; Mark Gilbert; Minesh Mehta
Journal:  J Clin Oncol       Date:  2005-12-01       Impact factor: 44.544

7.  Definitive, high-dose-per-fraction, conformal, stereotactic external radiation for renal cell carcinoma.

Authors:  Jonathan J Beitler; Denise Makara; Phillip Silverman; Gil Lederman
Journal:  Am J Clin Oncol       Date:  2004-12       Impact factor: 2.339

8.  Stereotactic radiosurgery for patients with "radioresistant" brain metastases.

Authors:  Paul D Brown; Cerise A Brown; Bruce E Pollock; Deborah A Gorman; Robert L Foote
Journal:  Neurosurgery       Date:  2008-02       Impact factor: 4.654

9.  Renal radiosurgery: initial clinical experience with histological evaluation.

Authors:  Lee E Ponsky; Arul Mahadevan; Indebir S Gill; Toufik Djemil; Andrew C Novick
Journal:  Surg Innov       Date:  2007-12       Impact factor: 2.058

10.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

View more
  1 in total

1.  Effect of Stereotactic Body Radiotherapy on the Growth Kinetics and Enhancement Pattern of Primary Renal Tumors.

Authors:  Maryellen R M Sun; Alexander Brook; Michael F Powell; Krithica Kaliannan; Andrew A Wagner; Irving D Kaplan; Ivan Pedrosa
Journal:  AJR Am J Roentgenol       Date:  2016-03       Impact factor: 3.959

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.